Odibo Anthony O, Francis Andre, Cahill Alison G, Macones George A, Crane James P, Gardosi Jason
Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Ultrasound and Genetics, Washington University School of Medicine, St Louis, MO 63110, USA.
J Matern Fetal Neonatal Med. 2011 Mar;24(3):411-7. doi: 10.3109/14767058.2010.506566. Epub 2010 Aug 10.
To derive coefficients for developing a customized growth chart for a Mid-Western US population, and to estimate the association between pregnancy outcomes and smallness for gestational age (SGA) defined by the customized growth chart compared with a population-based growth chart for the USA.
A retrospective cohort study of an ultrasound database using 54,433 pregnancies meeting inclusion criteria was conducted. Coefficients for customized centiles were derived using 42,277 pregnancies and compared with those obtained from other populations. Two adverse outcome indicators were defined (greater than 7 day stay in the neonatal unit and stillbirth [SB]), and the risk for each outcome was calculated for the groups of pregnancies defined as SGA by the population standard and SGA by the customized standard using 12,456 pregnancies for the validation sample.
The growth potential expressed as weight at 40 weeks in this population was 3524 g (standard error: 402 g). In the validation population, 4055 cases of SGA were identified using both population and customized standards. The cases additionally identified as SGA by the customized method had a significantly increased risk of each of the adverse outcome categories. The sensitivity and specificity of those identified as SGA by customized method only for detecting pregnancies at risk for SB was 32.7% (95% confidence interval [CI] 27.0-38.8%) and 95.1% (95% CI: 94.7-95.0%) versus 0.8% (95% CI 0.1-2.7%) and 98.0% (95% CI 97.8-98.2%)for those identified by only the population-based method, respectively.
SGA defined by customized growth potential is able to identify substantially more pregnancies at a risk for adverse outcome than the currently used national standard for fetal growth.
得出用于为美国中西部人群制定定制生长图表的系数,并评估与基于美国人群的生长图表相比,定制生长图表所定义的妊娠结局与小于胎龄儿(SGA)之间的关联。
对一个超声数据库进行回顾性队列研究,纳入54433例符合纳入标准的妊娠病例。使用42277例妊娠病例得出定制百分位数的系数,并与从其他人群获得的系数进行比较。定义了两个不良结局指标(新生儿病房住院时间超过7天和死产[SB]),并使用12456例妊娠病例作为验证样本,计算了根据人群标准定义为SGA的妊娠组和根据定制标准定义为SGA的妊娠组中每种结局的风险。
该人群中以40周体重表示的生长潜力为3524克(标准误:402克)。在验证人群中,使用人群标准和定制标准共识别出4055例SGA病例。通过定制方法额外识别为SGA的病例,每种不良结局类别的风险均显著增加。仅通过定制方法识别为SGA的病例对于检测有SB风险的妊娠的敏感性和特异性分别为32.7%(95%置信区间[CI]27.0 - 38.8%)和95.1%(95%CI:94.7 - 95.0%),而仅通过基于人群的方法识别的病例分别为0.8%(95%CI 0.1 - 2.7%)和98.0%(95%CI 97.8 - 98.2%)。
与目前使用的胎儿生长国家标准相比,由定制生长潜力定义的SGA能够识别出更多有不良结局风险的妊娠。